Over 8 million adults in the U.S. experience plaque psoriasis — a chronic autoimmune disease that causes painful, raised, scaly spots on the skin. People with plaque psoriasis often employ a host of ...
"Our study is an updated meta-analysis of more than 1.7 million individuals of different countries and shows that psoriasis is significantly associated with a nearly twofold increased odds of ...
Amgen today announced that the U.S. Food and Drug Administration (FDA) has approved Otezla® (apremilast) for the treatment of adult patients with plaque psoriasis who are candidates for phototherapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback